Authors:
- Peter Amstutz [email protected], Curii Inc. / Arvados; https://orcid.org/0000-0003-3566-7705
- Michael R. Crusoe [email protected], CWL Project Lead; https://orcid.org/0000-0002-2961-9670
- Kaushik Ghose [email protected], Seven Bridges Genomics, Inc; https://orcid.org/0000-0003-2933-1260
Contributors to v1.2:
- John Chilton [email protected], Galaxy Project, Pennsylvania State University; https://orcid.org/0000-0002-6794-0756
- Michael Franklin [email protected], Peter MacCallum Cancer Centre and University of Melbourne; https://orcid.org/0000-0001-9292-1533
- Bogdan Gavrilovic [email protected], Seven Bridges Genomics; https://orcid.org/0000-0003-1550-1716
- Stian Soiland-Reyes, University of Manchester; https://orcid.org/0000-0001-9842-9718
Incorporates the work of past authors and contributors to CWL v1.0 and CWL v1.1.
This specification was approved on 2020-08-07 by the CWL leadership team consisting of:
- Peter Amstutz, Curii Inc. / Arvados; https://orcid.org/0000-0003-3566-7705
- John Chilton, Pennsylvania State University / Galaxy Project; https://orcid.org/0000-0002-6794-0756
- Michael R. Crusoe, CWL Project Lead; https://orcid.org/0000-0002-2961-9670
- Brandi Davis Dusenbery, Seven Bridges Genomics, Inc.; https://orcid.org/0000-0001-7811-8613
- Jeff Gentry, Foundation Medicine; https://orcid.org/0000-0001-5351-8442
- Hervé Ménager, Institut Pasteur; https://orcid.org/0000-0002-7552-1009
- Stian Soiland-Reyes, University of Manchester; https://orcid.org/0000-0001-9842-9718